Navigation Links
Dallas Gastroenterologist Named Vice President of Prestigious National Organization
Date:5/15/2009

DALLAS, May 15 /PRNewswire-USNewswire/ -- C. Richard Boland, M.D., chief of gastroenterology at Baylor University Medical Center at Dallas, has been named vice president of the American Gastroenterological Association (AGA) Institute, a position that will evolve into the presidency in 2011. The oldest medical specialty society in the United States, the AGA is dedicated to advancing the science and practice of gastroenterology. AGA membership includes 16,500 physicians and scientists.

Dr. Boland is a nationally recognized physician with a long history of teaching, training post-doctoral fellows, serving the AGA, speaking throughout the country, publishing hundreds of papers and researching colon cancer.

Dr. Boland received his medical degree from Yale University School of Medicine in New Haven, Conn., and after completing his Internal Medicine training and two years in the Indian Health Service, completed his fellowship and was appointed Assistant Professor at the University of California, San Francisco. He then moved to the University of Michigan, where he rose to Professor of Internal Medicine.

After serving as the chief of the division of gastroenterology and associate director for clinical research at the University of California San Diego Cancer Center, Dr. Boland joined the medical staff at Baylor Dallas in 2003. Since coming to Dallas, Dr. Boland has focused entirely on colon cancer research with both laboratory-based and clinical programs designed to rapidly translate research results into diagnostic, preventive and treatment approaches. He has been funded by the National Institutes of Health for 30 years.

Dr. Boland has been a member of the AGA since 1978 and has served on numerous AGA committees and in numerous AGA leadership roles over the past 30 years.

About Baylor Dallas

Baylor University Medical Center at Dallas, a 1025-bed not-for-profit academic hospital, is a major patient care and research center in the southwest. The nationally acclaimed medical center serves as flagship hospital for Baylor Health Care System and has earned re-accreditation as a Magnet hospital for "Excellence in Nursing Services" from the American Nurses Credentialing Center. In addition to its Level 1 trauma center, Baylor Dallas is also home to many nationally ranked centers of excellence including transplant, cardiovascular services, orthopaedics, oncology, digestive diseases, neurosciences and gynecology. In 2008, U.S. News & World Report recognized Baylor Dallas in five specialty areas for the 16th consecutive year in its "America's Best Hospitals" guide.

Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor University Medical Center at Dallas or Baylor Health Care System.


'/>"/>
SOURCE Baylor University Medical Center at Dallas
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Edward Downs Named CEO of Renaissance Hospital Dallas
2. Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth
3. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
4. Baylor Dallas Nationally Recognized for Nursing Excellence
5. Dallas-Fort Worth Bariatric Surgeon Earns Top Honors from Two National Medical Organizations
6. Obama Notre Dame Abortion Tension Mounts: Good Friday Protests at White House, and in Dallas, Los Angeles, and Fort Wayne
7. Sheraton Dallas Hotel Provides Accommodations for Families Visiting Childrens Medical Center
8. Andrew Dallas, President of Full Spectrum Software Appointed to Medical Device and Diagnostic Industry Magazine Editorial Advisory Board
9. Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26
10. Dallas-based MedNetwoRx Leading the Way With Healthcare Reform
11. Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: